Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment
2012
Purpose
The aim of this study was to determine the plasma pharmacokinetics of eribulin mesylate in patients with solid tumors with mild and moderate hepatic impairment.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
28
References
32
Citations
NaN
KQI